Combining epigenetic therapies with immunotherapies likely to improve cancer patient outcomes
Tuesday, September 15, 2015 - 10:20
in Health & Medicine
Epigenetic therapies are likely to provide additional clinical benefit to cancer patients when rationally combined with immunotherapeutic drugs, according to a review.